Meeder Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-33
| Closed | -$1K | – | 1759 |
|
|
2022
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 2011 |
|
|
2022
Q2 | $1K | Sell |
33
-9
| -21% | -$273 | ﹤0.01% | 2070 |
|
|
2022
Q1 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 2239 |
|
|
2021
Q4 | – | Sell |
-7,995
| Closed | -$354K | – | 2116 |
|
|
2021
Q3 | $354K | Buy |
7,995
+6,695
| +515% | +$296K | 0.02% | 568 |
|
|
2021
Q2 | $74K | Buy |
1,300
+1,215
| +1,429% | +$69.2K | ﹤0.01% | 997 |
|
|
2021
Q1 | $6K | Buy |
85
+1
| +1% | +$71 | ﹤0.01% | 1812 |
|
|
2020
Q4 | $7K | Hold |
84
| – | – | ﹤0.01% | 1114 |
|
|
2020
Q3 | $5K | Buy |
84
+5
| +6% | +$298 | ﹤0.01% | 1587 |
|
|
2020
Q2 | $3K | Sell |
79
-17
| -18% | -$646 | ﹤0.01% | 1691 |
|
|
2020
Q1 | $3K | Buy |
96
+24
| +33% | +$750 | ﹤0.01% | 1986 |
|
|
2019
Q4 | $5K | Sell |
72
-29
| -29% | -$2.01K | ﹤0.01% | 1801 |
|
|
2019
Q3 | $14K | Sell |
101
-1
| -1% | -$139 | ﹤0.01% | 1423 |
|
|
2019
Q2 | $19K | Buy |
102
+66
| +183% | +$12.3K | ﹤0.01% | 1255 |
|
|
2019
Q1 | $6K | Buy |
+36
| New | +$6K | ﹤0.01% | 1370 |
|
|
2018
Q3 | – | Sell |
-1,896
| Closed | -$297K | – | 1671 |
|
|
2018
Q2 | $297K | Buy |
1,896
+1,507
| +387% | +$236K | 0.03% | 446 |
|
|
2018
Q1 | $63K | Buy |
389
+210
| +117% | +$34K | 0.01% | 623 |
|
|
2017
Q4 | $29K | Buy |
179
+163
| +1,019% | +$26.4K | ﹤0.01% | 826 |
|
|
2017
Q3 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1562 |
|